Corient Private Wealth’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $354K | Buy |
6,444
+1,710
| +36% | +$94K | ﹤0.01% | 1989 |
|
|
2025
Q1 | $335K | Buy |
+4,734
| New | +$335K | ﹤0.01% | 1798 |
|
|
2024
Q3 | – | Sell |
-4,286
| Closed | -$353K | – | 2429 |
|
|
2024
Q2 | $353K | Sell |
4,286
-322
| -7% | -$26.5K | ﹤0.01% | 1811 |
|
|
2024
Q1 | $402K | Buy |
4,608
+109
| +2% | +$9.52K | ﹤0.01% | 1735 |
|
|
2023
Q4 | $434K | Buy |
4,499
+429
| +11% | +$41.4K | ﹤0.01% | 1680 |
|
|
2023
Q3 | $361K | Sell |
4,070
-29
| -0.7% | -$2.57K | ﹤0.01% | 1650 |
|
|
2023
Q2 | $355K | Buy |
4,099
+172
| +4% | +$14.9K | ﹤0.01% | 1616 |
|
|
2023
Q1 | $382K | Sell |
3,927
-28
| -0.7% | -$2.72K | ﹤0.01% | 1480 |
|
|
2022
Q4 | $409K | Buy |
+3,955
| New | +$409K | ﹤0.01% | 1210 |
|